- Home
- / Alaunos Therapeutics
Alaunos Therapeutics
Stock Price
$2.1
2024-10-29
Market Capitalization
$3.3 M
2024-10-29
Alaunos Therapeutics Summary
Company Summary
- Overview
- Alaunos Therapeutics is a cell therapy company that specializes in cancer treatment solutions. It focuses on developing T-cell receptor (TCR) therapies for the treatment of solid tumors.
- Type
- Public
- Status
- Active
- Founded
- 2005
- Website
- https://alaunos.com/
- Cybersecurity rating
Table of Contents
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026